676 related articles for article (PubMed ID: 31978901)
21. Comparison of the radiomics-based predictive models using machine learning and nomogram for epidermal growth factor receptor mutation status and subtypes in lung adenocarcinoma.
Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
Phys Eng Sci Med; 2023 Mar; 46(1):395-403. PubMed ID: 36787023
[TBL] [Abstract][Full Text] [Related]
22. Imaging-Based Surrogate Markers of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma: A Local Perspective.
AlGharras A; Kovacina B; Tian Z; Alexander JW; Semionov A; van Kempen LC; Sayegh K
Can Assoc Radiol J; 2020 May; 71(2):208-216. PubMed ID: 32062999
[TBL] [Abstract][Full Text] [Related]
23. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
[TBL] [Abstract][Full Text] [Related]
24. Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT.
Jiang M; Zhang Y; Xu J; Ji M; Guo Y; Guo Y; Xiao J; Yao X; Shi H; Zeng M
Nucl Med Commun; 2019 Aug; 40(8):842-849. PubMed ID: 31290849
[TBL] [Abstract][Full Text] [Related]
25. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
[TBL] [Abstract][Full Text] [Related]
26. Clinical and radiological predictors of epidermal growth factor receptor mutation in nonsmall cell lung cancer.
Dang Y; Wang R; Qian K; Lu J; Zhang H; Zhang Y
J Appl Clin Med Phys; 2021 Jan; 22(1):271-280. PubMed ID: 33314737
[TBL] [Abstract][Full Text] [Related]
27. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients.
Ren M; Yang H; Lai Q; Shi D; Liu G; Shuang X; Su J; Xie L; Dong Y; Jiang X
Med Phys; 2021 Sep; 48(9):5142-5151. PubMed ID: 34318502
[TBL] [Abstract][Full Text] [Related]
28. Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
Han X; Fan J; Li Y; Cao Y; Gu J; Jia X; Wang Y; Shi H
Sci Rep; 2021 Mar; 11(1):5679. PubMed ID: 33707479
[TBL] [Abstract][Full Text] [Related]
29. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK
Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433
[TBL] [Abstract][Full Text] [Related]
30. 2D and 3D texture analysis to predict lymphovascular invasion in lung adenocarcinoma.
Yang G; Nie P; Zhao L; Guo J; Xue W; Yan L; Cui J; Wang Z
Eur J Radiol; 2020 Aug; 129():109111. PubMed ID: 32559593
[TBL] [Abstract][Full Text] [Related]
31. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
[TBL] [Abstract][Full Text] [Related]
32. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Interval Growth of Lung Adenocarcinomas Manifesting as Persistent Subsolid Nodules ≤3 cm Based on Radiomic Features.
Wu FZ; Wu YJ; Chen CS; Tang EK
Acad Radiol; 2023 Dec; 30(12):2856-2869. PubMed ID: 37080884
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma.
Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
J Appl Clin Med Phys; 2023 Jun; 24(6):e13980. PubMed ID: 37002910
[TBL] [Abstract][Full Text] [Related]
35. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.
Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW
Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309
[TBL] [Abstract][Full Text] [Related]
36. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.
Choe J; Lee SM; Kim W; Do KH; Kim S; Choi S; Seo JB
Eur J Radiol; 2021 Jun; 139():109710. PubMed ID: 33862316
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
[TBL] [Abstract][Full Text] [Related]
38. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X
Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860
[TBL] [Abstract][Full Text] [Related]
39. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a preoperative CT‑based radiomics nomogram to differentiate tuberculosis granulomas from lung adenocarcinomas: an external validation study.
Yang L; Jiang Z; Tong J; Li N; Dong Q; Wang K
BMC Cancer; 2024 Jun; 24(1):670. PubMed ID: 38824514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]